Page last updated: 2024-10-25

clioquinol and Hemorrhagic Disorders

clioquinol has been researched along with Hemorrhagic Disorders in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Hemorrhagic Disorders: Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ullrich, K1

Other Studies

1 other study available for clioquinol and Hemorrhagic Disorders

ArticleYear
[Why do dogs not tolerate mexaform?].
    Munchener medizinische Wochenschrift (1950), 1971, Dec-03, Volume: 113, Issue:49

    Topics: Animals; Clioquinol; Dog Diseases; Dogs; Epilepsy; Hemorrhagic Disorders; Ketones; Phenanthrolines;

1971